Health care companies by P/S ratio
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Centene has the lowest figure of the 154 health care companies ranked by P/S ratio, at 0.2, followed by Cencora (0.2) and Molina Healthcare (0.2). Figures as of 20 Nov 2026, 05:23 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 154
- Lowest
- Centene0.2
- Median
- 4.2
- Combined market value
- HUF 3034.25T
- Countries
- 14
- Not ranked
- 16no P/S ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/S ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | IlluminaILMN · Health Care | 7.0 | HUF 10.32T | HUF 68,246.18 | 4.45% down | 76% up | ||
| 102 | Medpace HoldingsMEDP · Health Care | 7.0 | HUF 6.03T | HUF 215,627.38 | 1.99% down | 10% up | ||
| 103 | Gilead SciencesGILD · Health Care | 7.0 | HUF 70.25T | HUF 56,639.68 | 1.45% down | 35% up | ||
| 104 | Agilent TechnologiesA · Health Care | 7.1 | HUF 16.82T | HUF 59,636.11 | 1.12% down | 22% up | ||
| 105 | Arrowhead PharmaceuticalsARWR · Health Care | 7.4 | HUF 2.1T | HUF 14,846.11 | 1.25% up | 13% up | ||
| 106 | United TherapeuticsUTHR · Health Care | 7.5 | HUF 8.1T | HUF 190,159.41 | 3.16% down | 22% up | ||
| 107 | Halozyme TherapeuticsHALO · Health Care | 7.6 | HUF 3.61T | HUF 31,644.49 | 2.88% down | 39% up | ||
| 108 | AbbVieABBV · Health Care | 8.2 | HUF 170.46T | HUF 96,436.77 | 0.86% down | 25% up | ||
| 109 | Mettler-Toledo InternationalMTD · Health Care | 8.4 | HUF 11.54T | HUF 580,123.96 | 1.82% down | 24% up | ||
| 110 | GenmabGMAB · Health Care | 8.5 | HUF 10.77T | HUF 17,465.01 | 0.75% up | 70% up | ||
| 111 | BeOne MedicinesONC · Health Care | 8.5 | HUF 15.53T | HUF 135,944.76 | 0.97% down | 16% up | ||
| 112 | PenumbraPEN · Health Care | 9.0 | HUF 4.29T | HUF 108,840.84 | 0.18% down | 15% up | ||
| 113 | West Pharmaceutical ServicesWST · Health Care | 9.0 | HUF 9.4T | HUF 134,921.01 | 1.81% down | 57% up | ||
| 114 | Corcept TherapeuticsCORT · Health Care | 9.3 | HUF 2.42T | HUF 22,100.80 | 4.15% down | 10% down | ||
| 115 | Bio-TechneTECH · Health Care | 9.4 | HUF 3.88T | HUF 24,726.51 | 0.07% down | 24% up | ||
| 116 | Travere TherapeuticsTVTX · Health Care | 9.4 | HUF 1.58T | HUF 16,427.65 | 3.86% down | 45% up | ||
| 117 | Madrigal PharmaceuticalsMDGL · Health Care | 9.6 | HUF 3.13T | HUF 134,938.02 | 0.34% down | 27% down | ||
| 118 | Edwards LifesciencesEW · Health Care | 9.8 | HUF 20.32T | HUF 35,331.35 | 1.28% down | 25% up | ||
| 119 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 10.8 | HUF 2.5T | HUF 31,812.84 | 1.59% down | 129% up | ||
| 120 | Vertex PharmaceuticalsVRTX · Health Care | 11.0 | HUF 44.9T | HUF 177,085.32 | 2.94% down | 27% up | ||
| 121 | Axsome TherapeuticsAXSM · Health Care | 11.2 | HUF 2.43T | HUF 46,147.07 | 1.25% up | 6% down | ||
| 122 | 10x GenomicsTXG · Health Care | 11.7 | HUF 2.57T | HUF 19,515.91 | 0.54% up | 247% up | ||
| 123 | Mirum PharmaceuticalsMIRM · Health Care | 12.0 | HUF 2.12T | HUF 32,484.57 | 3.27% up | 34% up | ||
| 124 | IDEXX LaboratoriesIDXX · Health Care | 12.6 | HUF 18.48T | HUF 234,561.69 | 1.26% down | 1% up | ||
| 125 | Intuitive SurgicalISRG · Health Care | 14.0 | HUF 48.01T | HUF 138,509.25 | 3.26% down | 24% down | ||
| 126 | BillionToOneBLLN · Health Care | 14.1 | HUF 1.47T | HUF 30,678.55 | 1.46% down | 4% down | ||
| 127 | argenxARGX · Health Care | 14.3 | HUF 20.15T | HUF 320,403.82 | 0.08% up | 2% up | ||
| 128 | RepligenRGEN · Health Care | 14.7 | HUF 3.7T | HUF 57,918.52 | 1.38% down | 12% up | ||
| 129 | TG TherapeuticsTGTX · Health Care | 15.9 | HUF 3.34T | HUF 22,066.79 | 1.88% down | 117% up | ||
| 130 | Royalty PharmaRPRX · Health Care | 16.4 | HUF 13.24T | HUF 23,032.72 | 1.38% down | 79% up | ||
| 131 | Adaptive BiotechnologiesADPT · Health Care | 16.4 | HUF 1.54T | HUF 9,540.28 | 1.44% down | 74% up | ||
| 132 | NateraNTRA · Health Care | 18.2 | HUF 14.3T | HUF 98,606.72 | 0.15% up | 28% up | ||
| 133 | Eli LillyLLY · Health Care | 18.5 | HUF 409.33T | HUF 459,538.88 | 2.29% down | 33% up | ||
| 134 | Guardant HealthGH · Health Care | 20.1 | HUF 6.7T | HUF 49,517.63 | 0.31% up | 45% up | ||
| 135 | Twist BioscienceTWST · Health Care | 20.2 | HUF 2.59T | HUF 37,963.86 | 4.07% down | 346% up | ||
| 136 | Ascendis PharmaASND · Health Care | 21.0 | HUF 5.71T | HUF 87,056.35 | 5.32% down | 29% up | ||
| 137 | Ligand PharmaceuticalsLGND · Health Care | 21.4 | HUF 1.95T | HUF 97,593.17 | 3.94% down | 50% up | ||
| 138 | HeartflowHTFL · Health Care | 22.3 | HUF 1.33T | HUF 15,179.42 | 2.75% down | 66% up | ||
| 139 | Krystal BiotechKRYS · Health Care | 24.1 | HUF 3.18T | HUF 107,415.75 | 0.15% up | 54% up | ||
| 140 | GlaukosGKOS · Health Care | 27.8 | HUF 4.79T | HUF 80,981.86 | 2.15% up | 145% up | ||
| 141 | WatersWAT · Health Care | 28.3 | HUF 30.51T | HUF 155,256.61 | 2.06% down | 23% up | ||
| 142 | BridgeBio PharmaBBIO · Health Care | 30.3 | HUF 5.18T | HUF 26,590.35 | 0.22% up | 21% up | ||
| 143 | GRAILGRAL · Health Care | 32.0 | HUF 1.6T | HUF 35,657.87 | 2.68% up | 19% up | ||
| 144 | ModernaMRNA · Health Care | 41.5 | HUF 27.43T | HUF 67,795.52 | 1.29% up | 780% up | ||
| 145 | Rhythm PharmaceuticalsRYTM · Health Care | 42.7 | HUF 2.75T | HUF 39,725.67 | 1.88% down | 18% up | ||
| 146 | InsmedINSM · Health Care | 52.3 | HUF 10.78T | HUF 49,133.30 | 20.58% up | 40% down | ||
| 147 | ImmunityBioIBRX · Health Care | 61.7 | HUF 2.38T | HUF 2,234.57 | 1.94% down | 232% up | ||
| 148 | CytokineticsCYTK · Health Care | 81.4 | HUF 2.44T | HUF 17,502.42 | 0.27% up | 19% down | ||
| 149 | Protagonist TherapeuticsPTGX · Health Care | 176 | HUF 2.75T | HUF 42,181.31 | 2.47% down | 51% up | ||
| 150 | Kymera TherapeuticsKYMR · Health Care | 260 | HUF 3.47T | HUF 40,606.57 | 1.44% down | 87% up | ||
| 151 | CRISPR TherapeuticsCRSP · Health Care | 1076 | HUF 1.28T | HUF 13,240.75 | 3.14% down | 18% down | ||
| 152 | CG OncologyCGON · Health Care | 1811 | HUF 2.49T | HUF 27,855.58 | 2.38% up | 97% up | ||
| 153 | Dianthus TherapeuticsDNTH · Health Care | 2346 | HUF 1.62T | HUF 28,852.13 | 1.01% up | 108% up | ||
| 154 | Roivant SciencesROIV · Health Care | 3418 | HUF 9.6T | HUF 13,250.96 | 0.59% up | 91% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 340.1 HUF). 16 companies have no P/S ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/S ratio?
Centene (0.2), Cencora (0.2) and Molina Healthcare (0.2) have the lowest P/S ratio of the 154 health care companies ranked here as of 20 Nov 2026, 05:23 UTC.
How many health care companies are in this ranking?
154 are ranked by P/S ratio. 16 more have no P/S ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 154 health care companies ranked by P/S ratio have a combined market value of HUF 3034.25T as of 20 Nov 2026, 05:23 UTC.
What does ranking by P/S ratio measure?
Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/S ratio”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=ps-ratio
Underlying data: Yahoo Finance; SEC EDGAR.